{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:29:56Z","timestamp":1761560996396},"reference-count":15,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> The permeabilities of normal human and normal, inflamed, or corticosteroid (CS) pretreated skin of young domestic pigs for pimecrolimus and tacrolimus were compared <jats:italic>in vitro<\/jats:italic>, using Franz\u2010type diffusion cells. The test articles were either used as 1.0% solutions or as the marketed formulations (Elidel 1% cream, Protopic 0.1%, and 0.03% ointment). In normal human skin, the permeation rate of pimecrolimus from the 1% cream was about sixfold lower than that of tacrolimus from 0.1% ointment and by a factor of 4.3 lower compared with tacrolimus from Protopic 0.03%. In pigs, sodium laurylsulfate\u2010induced irritant contact dermatitis resulted in significantly faster skin permeation of both drugs from applied solutions. The permeation rate for pimecrolimus was lower than that for tacrolimus. Thus, at 24\u2003h, pimecrolimus concentrations in the receptor fluid were 2.8\u2010fold lower than the tacrolimus levels. Compared with normal porcine skin, permeation of drugs through hydrocortisone (1.0%)\u2010, mometasone (0.1%)\u2010, or clobetasol\u201017\u2010butyrate (0.05%)\u2010pretreated skin was increased by factors of 3.6 (pimecrolimus, applied as 1% cream) and 1.7 (tacrolimus, applied as 0.1% ointment). In normal pig skin, the permeation rate of tacrolimus was found to be 11.2 times higher than that of pimecrolimus and 3.5\u2010 to 7.1\u2010fold higher in CS\u2010pretreated skin, independent of the potency of the CSs. The present <jats:italic>in vitro<\/jats:italic> data suggest that in patients with acute skin inflammation or after therapy with topical CSs, percutaneous absorption and, as a consequence, systemic drug exposure will be lower with Elidel 1% cream as compared with Protopic 0.1% and 0.03% ointment.<\/jats:p>","DOI":"10.1111\/j.1600-0625.2005.00354.x","type":"journal-article","created":{"date-parts":[[2005,9,19]],"date-time":"2005-09-19T08:04:06Z","timestamp":1127117046000},"page":"752-757","source":"Crossref","is-referenced-by-count":43,"title":["Pimecrolimus permeates less than tacrolimus through normal, inflamed, or corticosteroid\u2010pretreated skin"],"prefix":"10.1111","volume":"14","author":[{"given":"Josef G.","family":"Meingassner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Aschauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Stuetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Billich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12359.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0029(19970815)38:4<361::AID-JEMT4>3.0.CO;2-M"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120942"},{"key":"e_1_2_5_5_2","first-page":"1266","article-title":"Penetration of Sandimmune (Cyclosporine A) in rat skin in vitro","volume":"82","author":"Schmook F P","year":"1993","journal-title":"Skin Pharmacol"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2003.07.013"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(00)00665-7"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12491710"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.01827.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12053.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1983.12"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)38361-9"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.10.019"},{"issue":"2","key":"e_1_2_5_14_2","first-page":"369","article-title":"Topical pimecrolimus: a novel therapeutic option for Netherton syndrome","volume":"18","author":"Oji V","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"e_1_2_5_15_2","first-page":"160","article-title":"Comel\u2010Netherton syndrome: a case treated with topical pimecrolimus cream 1% (conference abstract)","volume":"18","author":"Thaci D","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_5_16_2","first-page":"747","article-title":"Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome","volume":"37","author":"Allen A","year":"2001","journal-title":"Arch Dermatol"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0625.2005.00354.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0625.2005.00354.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:54:43Z","timestamp":1697061283000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0625.2005.00354.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1600-0625.2005.00354.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0625.2005.00354.x","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}